BBS-Bioactive Bone Substitutes Plc

INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM)

Stock Exchange Release April 7th, 2021 at 6.00 pm

INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM)

The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s Annual General Meeting, which is held at the company’s premises at Kiviharjunlenkki 6, 90220 Oulu, on Wednesday April 28^th  2021 starting at 2.00 pm. At the AGM the right to participate and the right to vote are held by the shareholders registered in the shareholder register on the record date April 14^th 2021. Shareholders through the nominee register must register for the meeting by April 23^rd 2021 at 10.00 at the least.

A. MATTERS TO BE DEALT WITH AT THE ANNUAL GENERAL MEETING

1. Opening of the AGM
2. Election of the chairman and the secretary
3. Election of person to scrutinise the minutes and persons to supervise the counting of votes
4. Recording the legality of the meeting
5. Recording the attendance at the meeting and adoption of the list of votes
6. Presentation of the financial statements for the year ended December 31^st  2020, the report of the Board of Directors and the auditor’s report.

CEO’s Review

7. Decide on the approval of the income statement and balance sheet
8. Resolution on the use of the profit shown on the balance sheet and the payment of dividends

The Board of Directors proposes that the result for the financial year be transferred to the previous profit and loss account and no dividend is distributed

9. Resolution on the discharge of the members of the Board of Directors and the President and CEO from liability
10. Resolution on the remuneration of the members of the Board of Directors
11. Resolution on the number of members of the Board of Directors (3-7)
12. Election of the members of the Board of Directors
13. Resolution on the auditor’s remuneration
14. Election of the auditor
15. Authorising the Board to decide on the issuance of shares and the issuance of special rights entitling to shares.

The Board proposes to the AGM at April 28^th  2020 at 2.00 pm that the Board be authorised to decide on the issuance of the shares. The proposed authorisation includes the right to deviate from the shareholders' pre-emptive rights, provided that the Company has a significant financial reason to do so.